CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
3.490
+0.010 (0.29%)
May 17, 2024, 4:00 PM EDT - Market closed

CureVac Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018
Net Income
-260.17-249.03-411.72-129.12-99.87
Upgrade
Depreciation & Amortization
23.3923.7415.6710.677.16
Upgrade
Share-Based Compensation
7.79.1914.9614.2419.56
Upgrade
Other Operating Activities
-38.8-70.07-352.04626.61-13.82
Upgrade
Operating Cash Flow
-267.89-286.18-733.13522.4-86.96
Upgrade
Capital Expenditures
-52.32-88.02-124.22-36.33-11.17
Upgrade
Acquisitions
0-0.28000
Upgrade
Change in Investments
000-1.1638.08
Upgrade
Other Investing Activities
-2.88-5.2-3.68-7.781.27
Upgrade
Investing Cash Flow
-55.2-93.5-127.9-45.2728.18
Upgrade
Share Issuance / Repurchase
236.0967.39373.15867.720
Upgrade
Debt Issued / Paid
-5.19-4.22-28.18-47.8867.98
Upgrade
Financing Cash Flow
230.8963.17344.96819.8367.98
Upgrade
Exchange Rate Effect
-1.150.844.94-5.050.11
Upgrade
Net Cash Flow
-92.19-316.5-516.071,2979.2
Upgrade
Free Cash Flow
-320.21-374.2-857.35486.07-98.14
Upgrade
Free Cash Flow Margin
-595.65%-555.03%-832.46%994.61%-563.48%
Upgrade
Free Cash Flow Per Share
-1.43-1.97-4.582.75-0.56
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).